With the analysis among 1,987 patents, we discovered top 401 key players by total patent application. Bavarian Nordic A/S, Oncorus, Inc., Oxford Biomedica (UK) Ltd. are dominant in this area. They take 9.01% of the total patent filing.
Hovedstaden, Denmark
Patent: 84
Massachusetts, United States
Patent: 48
Oxford Biomedica (UK) Ltd.
Louisiana, United States
Patent: 46
Intervet International BV
Noord-Brabant, Netherlands
Patent: 37
Autoimmune Technologies LLC
Louisiana, United States
Patent: 35
California, United States
Patent: 31
Voyager Therapeutics, Inc.
Massachusetts, United States
Patent: 30
With the analysis among 150 patents, we discovered top 11 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, Agenovir Corp., Kalivir Immunotherapeutics are active in this area.
Institut National de la Santé et de la Recherche Médicale
California, United States
Patent: 31
Kalivir Immunotherapeutics
Pennsylvania, United States
Patent: 18
Shenzhen Immvira Pharma Co., Ltd.
Guangdong Sheng, China
Patent: 11
Replicate Bioscience, Inc.
California, United States
Patent: 8
Emergex Vaccines Holding Ltd.
Excision BioTherapeutics, Inc.
Pennsylvania, United States
Patent: 7
Hangzhou Jieyi Biotechnology Co. Ltd.
Zhejiang Sheng, China
Patent: 2
Guangzhou Ruifeng Biological Technology Co., Ltd.
Guangdong Sheng, China
Patent: 1
New York, United States
Patent: 1
With the analysis among related 660 patents applied in the last 5 years. We discover 249 most active companies in this area. The fast-growing Oncorus, Inc., Voyager Therapeutics, Inc., Kalivir Immunotherapeutics take 11.21% of patent filing during this period.
Massachusetts, United States
Patent: 37
Voyager Therapeutics, Inc.
Massachusetts, United States
Patent: 19
Kalivir Immunotherapeutics
Pennsylvania, United States
Patent: 18
Tenaya Therapeutics, Inc.
California, United States
Patent: 16
President & Fellows of Harvard College
Massachusetts, United States
Patent: 16
The Chinese University of Hong Kong
Hong Kong SAR, China
Patent: 14
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 10
Basel-Stadt, Switzerland
Patent: 10
Replicate Bioscience, Inc.
California, United States
Patent: 8
With the analysis among related 660 patents in last 5 years, we discover 160 new entrants. Kalivir Immunotherapeutics, Tenaya Therapeutics, Inc., The Chinese University of Hong Kong are the most active new entrants in this area.
Kalivir Immunotherapeutics
Pennsylvania, United States
Patent: 18
Tenaya Therapeutics, Inc.
California, United States
Patent: 16
The Chinese University of Hong Kong
Hong Kong SAR, China
Patent: 14
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 10
Replicate Bioscience, Inc.
California, United States
Patent: 8
Emergex Vaccines Holding Ltd.
Academy of Military Medical Sciences
Queensland, Australia
Patent: 6
Charles River Laboratories, Inc.
Massachusetts, United States
Patent: 5
Institute of Plant Protection, Chinese Academy of Agricultural Sciences
undefined undefined
Patent: 5
With the analysis among 1,201 patents, we discovered top 159 universities and scientific research institutions by total patent application. University of Saskatchewan, President & Fellows of Harvard College, Texas A&M University are dominant in this area. They take 16.24% of the total patent filing.
University of Saskatchewan
Saskatchewan, Canada
Patent: 26
President & Fellows of Harvard College
Massachusetts, United States
Patent: 24
Texas, United States
Patent: 22
The University of North Carolina at Chapel Hill
North Carolina, United States
Patent: 21
Queen's University of Belfast
Belfast, United Kingdom
Patent: 21
Icahn School of Medicine at Mount Sinai
New York, United States
Patent: 20
Thomas Jefferson University
Pennsylvania, United States
Patent: 15
Jiangsu Sheng, China
Patent: 15
The Chinese University of Hong Kong
Hong Kong SAR, China
Patent: 14
Basel-Stadt, Switzerland
Patent: 14